Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
2.150
-0.070 (-3.15%)
Nov 13, 2026, 3:00 PM CST
SHA:600252 Revenue
Guangxi Wuzhou Zhongheng Group had revenue of 275.98M CNY in the quarter ending September 30, 2026, a decrease of -44.48%. This brings the company's total for the last twelve months to 1.22B, down -28.43% year-over-year. In the year 2025, Guangxi Wuzhou Zhongheng Group had annual revenue of 1.75B, down -16.92%. That makes Guangxi Wuzhou Zhongheng Group the 18,121st largest company in the world by revenue and 3,310th in China.
Revenue (ttm)
1.22B
Revenue Growth
-28.43%
P/S Ratio
5.61
Revenue / Employee
429.56K
Employees
2,843
Market Cap
6.85B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600252 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.75B | -356.17M | -16.92% |
| Dec 31, 2024 | 2.10B | -991.78M | -32.03% |
| Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
| Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
| Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.59B |
| Shandong Lukang Pharmaceutical | 5.74B |
| Beijing Foyou Pharma CO.,LTD | 3.61B |
| Zhejiang Tianyu Pharmaceutical | 3.58B |
| Renhe Pharmacy Co.,Ltd | 3.49B |
| Jiangsu Kanion Pharmaceutical | 3.37B |
| Jiuzhitang | 2.79B |
| Sunflower Pharmaceutical Group | 2.75B |